Tic disorder in children
Conditions
Interventions
TCM granules :Oral TCM granules
Tiapride Hydrochioride Tablets and ChangMaXiFeng Pian:Oral Tiapride Hydrochioride Tablets and ChangMaXiFeng Pian
Tiapride Hydrochioride Tablets:Tiapride Hydrochioride Tablets
Sponsors
Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1)Diagnosis of tic disorder, Tourette syndrome, persistent (chronic) motor or vocal tic disorder by criteria of Diagnostic and Statistical Manual of Mental Disorders (DSM-5); 25= YGTSS score <50. 2)Diagnosis criteria of TCM syndrome according to the 2012 Chinese Society of Chinese Medicine and TCM Academy, TCM syndrome differentiation, complaining, frowning, blinking, shaking head, frequent muscle movements, yelling, high voice; secondary symptoms: irritability, dizziness, headache, restlessness, inattention. Tongue image pulse: red tongue, white or slightly yellow moss, smooth and strong veins. Patients with 3 or more main diseases and 2 or more secondary diseases can be diagnosed combined with tongue and pulse images. 3)The classification and quantitative standard of TCM syndrome refer to the TCM Pediatric Clinical Diagnosis and Treatment Guidelines. 4)Age is from 5 to 14 years old. 5)Meet the above diagnostic criteria. 6)The subject and the legal guardian read and fully understood the patient instructions, with informed consent.
Exclusion criteria
Exclusion criteria: 1) Those who do not meet the above diagnostic standards of Western medicine and traditional Chinese medicine; 2) The child and the legal guardian refused to accept the follow-up observers; 3) Previous history of dance disorder, HFMD, autism, Wilson disease, childhood schizophrenia, epilepsy, pharmacokinetic disorder, late-onset movement disorder, hysteria or acute movement disorder; 4) Taking other psychotropic drugs at the same time; 5) Abnormal maternal pregnancy and abnormal birth history; 6) Patients with obvious abnormal liver and kidney function and urine routine returns; 7) Also participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| YGTSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;CGI-?; | — |
Countries
China
Contacts
Public ContactJi Li
Outcome results
None listed